Imaging assessment and radiological features of pancreatic cystic lesions.

The present review provides a comprehensive analysis of the current role and limitations of imaging in the evaluation and management of pancreatic cystic lesions (PCLs). High-resolution modalities such as Magnetic Resonance Imaging (MRI) and Computed Tomography (CT), especially when integrated with Magnetic Resonance Cholangiopancreatography (MRCP), remain fundamental for lesion detection, characterization, and surveillance. However, significant variability in measurement practices, guideline recommendations, and imaging protocols poses ongoing challenges. Advances in artificial intelligence and radiomics show potential in improving diagnostic precision and risk stratification, though widespread clinical adoption is still constrained by methodological and infrastructural barriers. Emphasis is placed on the need for standardized imaging strategies and multidisciplinary collaboration to improve outcomes and tailor surveillance to individual patient risk.